PAD2 vs PAD4 Enzyme Selectivity Mapped Across 256 Peptides
A combinatorial peptide library reveals stark differences in how PAD2 and PAD4 enzymes citrullinate arginine—key to arthritis and neurodegeneration.
Summary
Researchers systematically mapped how PAD2 and PAD4 enzymes citrullinate arginine residues by synthesizing 256 combinatorial peptides and analyzing them with advanced mass spectrometry. PAD2 proved broadly active, efficiently modifying 233 of 256 peptides, while PAD4 was far more selective, with flanking amino acids dramatically affecting activity. Proline at the C-terminal position strongly blocked citrullination for both enzymes, while asparagine at either flanking position enhanced it. These findings clarify the distinct substrate rules governing each enzyme and highlight a critical analytical challenge: asparagine-enhanced citrullination can be confused with asparagine deamidation, a common source of false positives in proteomics studies.
Detailed Summary
Protein citrullination—the conversion of arginine to citrulline by peptidyl arginine deiminase (PAD) enzymes—is an irreversible post-translational modification linked to rheumatoid arthritis, multiple sclerosis, Alzheimer's disease, and cancer. Despite growing disease relevance, the precise sequence rules governing which arginine residues PAD2 and PAD4 preferentially modify have remained incompletely understood, with prior studies producing conflicting results.
To resolve this, researchers designed a combinatorial library of 256 synthetic 9-mer peptides following the template H-ASAZ1RZ2ASA-NH2, where 16 natural amino acids (excluding Cys, Met, Trp, and Arg) were systematically varied at the positions immediately flanking the central arginine. Peptides were synthesized using split-and-mix solid-phase synthesis, grouped to avoid isobaric and isomeric overlaps, then incubated with human recombinant PAD2 or PAD4. Citrullination efficiency was quantified by LC-HDMSE mass spectrometry enhanced with cyclic ion mobility separation, allowing discrimination of structurally similar peptides and unambiguous identification of citrullinated versus deamidated species.
The results revealed a striking divergence in enzyme behavior. PAD2 was broadly permissive, achieving ≥92% citrullination efficiency across 233 of 256 peptides. Only glutamate and proline at the C-terminal flanking position meaningfully reduced PAD2 activity. PAD4, by contrast, was far more restrictive: proline at the C-terminal position nearly abolished citrullination, and multiple amino acids at the N-terminal flanking position also negatively impacted efficiency. This confirms and quantifies the long-held view that PAD4 is the more regioselective enzyme, while providing the first multidimensional substrate map derived from a systematically varied, defined peptide set.
A particularly notable finding was that asparagine at either flanking position enhanced citrullination efficiency for both PAD2 and PAD4. This is analytically consequential because citrullination (Arg→Cit) and asparagine deamidation both produce a mass shift of 0.9840 Da, making them nearly indistinguishable by standard mass spectrometry. The proximity of asparagine to a citrullination site therefore increases the risk of misidentification in proteomics workflows, underscoring the need for high-resolution, fragment-ion-level verification.
These findings provide the most comprehensive substrate specificity map yet generated for PAD2 and PAD4, offering actionable sequence rules for predicting citrullination sites in disease-relevant proteins. The data could inform the development of PAD inhibitors, improve computational models for predicting citrullination in proteomes, and refine mass spectrometry protocols to reduce false positives in citrullination studies.
Key Findings
- PAD2 citrullinated 233 of 256 peptides at ≥92% efficiency, demonstrating broad substrate tolerance.
- PAD4 was far more selective; proline at the C-terminal flanking position nearly abolished its activity.
- Asparagine at either flanking position enhanced citrullination for both PAD2 and PAD4.
- Glutamate and proline at the C-terminal position were the primary inhibitors of PAD2 activity.
- Asparagine proximity to citrullination sites creates a critical false-positive risk in proteomics workflows.
Methodology
A library of 256 synthetic 9-mer peptides was built using split-and-mix combinatorial solid-phase synthesis, varying 16 amino acids at positions flanking a central arginine. Peptides were incubated with recombinant human PAD2 or PAD4, then analyzed by UPLC-HDMSE with cyclic ion mobility separation to quantify citrullination efficiency and distinguish citrullination from deamidation via manual MS/MS spectral interpretation.
Study Limitations
The study used short synthetic peptides rather than full-length proteins, so secondary structure and long-range sequence context effects are not captured. Four amino acids (Cys, Met, Trp, Arg) were excluded due to oxidation susceptibility, leaving gaps in the full sequence space. Assay conditions used a single enzyme concentration and defined buffer, which may not fully replicate the variable intracellular environments where PAD enzymes operate.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: